BB&T Securities’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $2.95M | Sell |
12,677
-1,916
| -13% | -$446K | 0.03% | 487 |
|
|
2019
Q2 | $3.41M | Sell |
14,593
-1,667
| -10% | -$385K | 0.03% | 458 |
|
|
2019
Q1 | $3.84M | Buy |
16,260
+3,381
| +26% | +$1.06M | 0.04% | 430 |
|
|
2018
Q4 | $3.88M | Sell |
12,879
-316
| -2% | -$101K | 0.04% | 406 |
|
|
2018
Q3 | $4.66M | Sell |
13,195
-1,233
| -9% | -$425K | 0.05% | 409 |
|
|
2018
Q2 | $4.19M | Buy |
14,428
+1,254
| +10% | +$353K | 0.04% | 416 |
|
|
2018
Q1 | $3.61M | Sell |
13,174
-678
| -5% | -$210K | 0.04% | 445 |
|
|
2017
Q4 | $4.41M | Buy |
13,852
+65
| +0.5% | +$20.9K | 0.06% | 357 |
|
|
2017
Q3 | $4.32M | Buy |
13,787
+798
| +6% | +$236K | 0.06% | 362 |
|
|
2017
Q2 | $3.52M | Buy |
12,989
+2,598
| +25% | +$687K | 0.05% | 387 |
|
|
2017
Q1 | $2.84M | Buy |
10,391
+1,702
| +20% | +$481K | 0.04% | 394 |
|
|
2016
Q4 | $2.72M | Hold |
8,689
| – | – | 0.04% | 368 |
|
|
2016
Q3 | $2.72M | Sell |
8,689
-2,775
| -24% | -$822K | 0.04% | 368 |
|
|
2016
Q2 | $2.77M | Sell |
11,464
-169
| -1% | -$44.5K | 0.04% | 363 |
|
|
2016
Q1 | $3.03M | Buy |
11,633
+289
| +3% | +$76.3K | 0.05% | 323 |
|
|
2015
Q4 | $3.48M | Buy |
11,344
+5,103
| +82% | +$1.47M | 0.07% | 250 |
|
|
2015
Q3 | $1.82M | Buy |
6,241
+1,766
| +39% | +$583K | 0.04% | 365 |
|
|
2015
Q2 | $1.81M | Buy |
4,475
+150
| +3% | +$60.2K | 0.04% | 371 |
|
|
2015
Q1 | $18.3M | Buy |
4,325
+929
| +27% | +$366K | 0.04% | 361 |
|
|
2014
Q4 | $11.5M | Buy |
3,396
+887
| +35% | +$287K | 0.03% | 469 |
|
|
2014
Q3 | $8.3M | Buy |
2,509
+289
| +13% | +$95.3K | 0.02% | 523 |
|
|
2014
Q2 | $7M | Buy |
2,220
+605
| +37% | +$182K | 0.02% | 568 |
|
|
2014
Q1 | $4.94M | Buy |
1,615
+196
| +14% | +$62.2K | 0.01% | 600 |
|
|
2013
Q4 | $3.97M | Buy |
1,419
+229
| +19% | +$59.2K | 0.01% | 638 |
|
|
2013
Q3 | $2.87M | Buy |
1,190
+195
| +20% | +$43.6K | 0.01% | 671 |
|
|
2013
Q2 | $2.14K | Buy |
+995
| New | +$213K | 0.01% | 724 |
|